MGC Pharmaceuticals Limited
MGCLF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -28.4% | 57.9% | 44.1% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 38% | 33% | 24.6% | -14.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -601.6% | -320.4% | -569.1% | -897.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -614.6% | -430% | -529.7% | -931.4% |
| EPS Diluted | -7.07 | -7.9 | -8.3 | -14 |
| % Growth | 10.5% | 4.8% | 40.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |